Deregulation of long noncoding RNA SNHG17 and TTC28-AS1 is associated with type 2 diabetes mellitus

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 (Suppl. 1):S81–S90.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.
   PubMed Web of Science ®Google Scholar
• Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud. 2012;9(1):6–22.
   PubMedGoogle Scholar
• Sanghera DK, Blackett PR. Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab. 2012;3:pii: 6948.
   Google Scholar
• Kameswaran V, Kaestner KH. The missing lnc(RNA) between the pancreatic β-cell and diabetes . Front Genet. 2014;5:200.
   PubMed Web of Science ®Google Scholar
• Wu R, Su Y, Wu H, et al. Characters, functions and clinical perspectives of long non-coding RNAs. Mol Genet Genomics. 2016;291(3):1013–1033.
   PubMed Web of Science ®Google Scholar
• Ruan X. Long non-coding RNA central of glucose homeostasis. J Cell Biochem. 2016;117(5):1061–1065.
   PubMed Web of Science ®Google Scholar
• Leti F, DiStefano JK. Long noncoding RNAs as diagnostic and therapeutic targets in type 2 diabetes and related complications. Genes (Basel). 2017;8:pii: E207.
   Web of Science ®Google Scholar
• Wang K, Li WD, Zhang CK, et al. A genome-wide association study on obesity and obesity-related traits. PLoS One. 2011;6(4):e18939.
   PubMed Web of Science ®Google Scholar
• Rotroff DM, Pijut SS, Marvel SW, et al. Genetic variants in HSD17B3, SMAD3, and IPO11 impact circulating lipids in response to fenofibrate in individuals with type 2 diabetes. Clin Pharmacol Ther. 2018;103(4):712–721.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2018 abridged for primary care providers. Clin Diabetes. 2018;36:14–37.
   PubMedGoogle Scholar
• Erfanian Omidvar M, Ghaedi H, Kazerouni F, et al. Clinical significance of long noncoding RNA VIM-AS1 and CTBP1-AS2 expression in type 2 diabetes. J Cell Biochem. 2019;120(6):9315–9323.
   PubMed Web of Science ®Google Scholar
• Chen EY, Tan CM, Kou Y, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.
   PubMed Web of Science ®Google Scholar
• Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–1335.
   PubMed Web of Science ®Google Scholar
• Uusitupa M. Lifestyles matter in the prevention of type 2 diabetes. Diab Care. 2002;25(9):1650–1651.
   PubMed Web of Science ®Google Scholar
• Leung A, Natarajan R. Long noncoding RNAs in diabetes and diabetic complications. Antioxid Redox Signal. 2018;29(11):1064–1073.
   PubMed Web of Science ®Google Scholar
• Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–589.
   PubMed Web of Science ®Google Scholar
• Pasmant E, Sabbagh A, Vidaud M, et al. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011;25(2):444–448.
   PubMed Web of Science ®Google Scholar
• Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA. 2009;106(23):9362–9367.
   PubMed Web of Science ®Google Scholar
• Imamura M, Maeda S, Yamauchi T, et al. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet. 2012;21(13):3042–3049.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao Z, Gao C, et al. The diagnostic value of whole blood lncRNA ENST00000550337.1 for pre-diabetes and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2017;125:377–383.
   PubMed Web of Science ®Google Scholar
• Saeidi L, Ghaedi H, Sadatamini M, et al. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus. Mol Biol Rep. 2018;45(6):2601–2608.
   PubMed Web of Science ®Google Scholar
• Mansoori Z, Ghaedi H, Sadatamini M, et al. Downregulation of long non-coding RNAs LINC00523 and LINC00994 in type 2 diabetes in an Iranian cohort. Mol Biol Rep. 2018;45(5):1227–1233.
   PubMed Web of Science ®Google Scholar
• Carter G, Miladinovic B, Patel AA, et al. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clin. 2015;4:102–107.
   PubMed Web of Science ®Google Scholar
• van Solingen C, Scacalossi KR, Moore KJ. Long noncoding RNAs in lipid metabolism. Curr Opin Lipidol. 2018;29(3):224–232.
   PubMed Web of Science ®Google Scholar
• Chen Z. Progress and prospects of long noncoding RNAs in lipid homeostasis. Mol Metab. 2016;5(3):164–170.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lim NK, Choi SJ, et al. Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study. Hypertens Res. 2015;38(11):783–789.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Laukkanen JA, Li Q, et al. Body mass index is associated with type 2 diabetes mellitus in Chinese elderly. Clin Interv Aging. 2017;12:745–752.
   PubMed Web of Science ®Google Scholar
• Taylor R. Insulin resistance and type 2 diabetes. Diabetes. 2012;61(4):778–779.
   PubMed Web of Science ®Google Scholar
• Xie J, Herbert TP. The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes. Cell Mol Life Sci. 2012;69(8):1289–1304.
   PubMed Web of Science ®Google Scholar
• Fischbach S, Gittes GK. The role of TGF-[beta] signaling in [beta]-cell dysfunction and type 2 diabetes: a review. J Cytol Histol. 2014;05(06):1.
   Google Scholar
• Kapadia KB, Bhatt PA, Shah JS. Association between altered thyroid state and insulin resistance. J Pharmacol Pharmacother. 2012;3(2):156–160.
   PubMedGoogle Scholar
• Yang H, Yang L. Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy. J Mol Endocrinol. 2016;57(2):R93–R108.
   PubMed Web of Science ®Google Scholar